Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
AVIDITY BIOSCIENCES INC
RNAM·05370A108·US·Common Stock·Healthcare - Biotechnology-Activist
RNAM (AVIDITY BIOSCIENCES INC) is held by 0 institutional investors as of Q1 2026.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold RNAM.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $44.9M | 0.0% | -78.28% | 0 | |
Exited | 0(-100.0%) | $244,852 | 0.0% | -6.43% | 0 | |
Exited | 0(-100.0%) | $7.9M | 0.0% | -44.55% | 0 | |
Exited | 0(-100.0%) | $263,491 | 0.0% | -17.47% | 0 | |
Exited | 0(-100.0%) | $6M | 0.0% | -61.03% | 0 | |
Exited | 0(-100.0%) | $1.8M | 0.0% | -37.43% | 0 | |
Exited | 0(-100.0%) | $5.4M | 0.0% | -78.28% | 0 | |
Exited | 0(-100.0%) | $12M | 0.0% | -37.07% | 0 | |
Exited | 0(-100.0%) | $38.3M | 0.0% | +5.41% | 0 | |
Exited | 0(-100.0%) | $369,000 | 0.0% | -46.30% | 0 | |
Exited | 0(-100.0%) | $3.2M | 0.0% | -57.78% | 0 | |
Exited | 0(-100.0%) | $4M | 0.0% | -78.28% | 0 | |
Exited | 0(-100.0%) | $432,780 | 0.0% | -61.28% | 0 | |
Exited | 0(-100.0%) | $233.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $391,810 | 0.0% | -78.28% | 0 | |
Exited | 0(-100.0%) | $60.7M | 0.0% | -78.28% | 0 | |
Exited | 0(-100.0%) | $59.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.1M | 0.0% | -62.11% | 0 | |
Exited | 0(-100.0%) | $403,062 | 0.0% | -45.90% | 0 | |
Exited | 0(-100.0%) | $73 | 0.0% | -78.28% | 0 |
Showing 1-20 of 155
1 / 8
RNAMAVIDITY BIOSCIENCES INCContinue exploring
Other Healthcare stocks held by institutions
LLYEli Lilly & Co.415 holders · $877.5B
UNHUnitedHealth Group Inc.415 holders · $299.1B
TMOThermo Fisher Scientific Inc400 holders · $151.4B
JNJJohnson & Johnson397 holders · $414.1B
DHRDanaher Corporation394 holders · $97.5B
ISRGIntuitive Surgical Inc.393 holders · $111.5B
MRKMerck & Co., Inc390 holders · $230.1B
ABBVAbbVie Inc.385 holders · $302.9B
BSXBoston Scientific Corporation385 holders · $51.8B
ABTAbbott Laboratories382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer